Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 457

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Hepatitis B Vaccine in Patients Receiving Hemodialysis: Immunogenicity and Efficacy

Stevens, Cladd E., Alter, Harvey J., Taylor, Patricia E., Zang, Edith A., Harley, Edward J., Szmuness, Wolf, the Dialysis Vaccine Trial Study Group·1984·New England Journal of Medicine

Abstract

We evaluated the immunogenicity and efficacy of hepatitis B vaccine (Heptavax-B) in a randomized, double-blind, placebo-controlled trial involving 1311 patients receiving hemodialysis in the United States. After three doses of vaccine (40 micrograms each) had been administered, 63 per cent of the patients were antibody-positive. After correction for possible passive transfer of antibodies by blood transfusion, only 50 per cent of vaccine recipients were considered vaccine responders. The incidence of hepatitis B viral infection during the 25 months of the trial was much lower than had been anticipated and was virtually the same in the vaccine and placebo recipients (6.4 and 5.4 per cent, respectively). Four cases of hepatitis B occurred in patients who had an apparent antibody response to the vaccine, but in each case either antibody had reached low or undetectable levels before hepatitis B surface antigen was detected or the patient had been receiving immunosuppressive therapy. This study did not demonstrate the efficacy of the vaccine in a population of patients receiving dialysis in whom both the rate of antibody response to hepatitis B vaccine and the viral attack rate were low. Other measures to control transmission of hepatitis B virus in dialysis units, including surveillance for hepatitis B surface antigen and isolation of patients who are positive for the antigen, must be continued.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejm198408233110803

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 457

Metadata

Authors
Stevens, C. E., Alter, H. J., Taylor, P. E., Zang, E. A., Harley, E. J., Szmuness, W., & the Dialysis Vaccine Trial Study Group
Venue
New England Journal of Medicine
Published
1984-08-23
Volume
311
Issue
8
Pages
496-501
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2056524016
Cited by
457
References
8
FWCI
25.34
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hepatitis B Vaccine in Patients Receiving Hemodialysis: Immunogenicity and Efficacy. https://app.cochat.ai/papers/10.1056/nejm198408233110803
The paper
Stevens, C. E., Alter, H. J., Taylor, P. E., Zang, E. A., Harley, E. J., Szmuness, W., & the Dialysis Vaccine Trial Study Group. (1984). Hepatitis B Vaccine in Patients Receiving Hemodialysis: Immunogenicity and Efficacy. New England Journal of Medicine. https://doi.org/10.1056/nejm198408233110803

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.